Samundeshwari E, Kattaru S, Kodavala S, Chandrasekhar C, Sarma P
Front Cell Dev Biol. 2025; 12:1450543.
PMID: 39744010
PMC: 11688275.
DOI: 10.3389/fcell.2024.1450543.
Perry N, Braun R, Ben-Hamo-Arad A, Kanaan D, Arad T, Porat-Kuperstein L
Aging Cell. 2024; 23(6):e14131.
PMID: 38450871
PMC: 11166360.
DOI: 10.1111/acel.14131.
Ahn S, Koh B, Lee J, Hong S, Kim I, Kim P
FASEB Bioadv. 2022; 4(8):547-559.
PMID: 35949509
PMC: 9353502.
DOI: 10.1096/fba.2021-00164.
Chen Z, Huo D, Li L, Liu Z, Li Z, Xu S
J Exp Med. 2021; 218(5).
PMID: 33755722
PMC: 7992411.
DOI: 10.1084/jem.20201974.
Hopner S, Raykova A, Radpour R, Amrein M, Koller D, Baerlocher G
Nat Commun. 2021; 12(1):1065.
PMID: 33594067
PMC: 7887212.
DOI: 10.1038/s41467-021-21317-x.
Protective effects of cytokine combinations against the apoptotic activity of glucocorticoids on CD34 hematopoietic stem/progenitor cells.
Kuruca S, Cetin M, Dar K, Ozerkan D
Cytotechnology. 2019; 71(1):67-77.
PMID: 30603917
PMC: 6368496.
DOI: 10.1007/s10616-018-0265-x.
A model of hematopoietic bone marrow apoptosis during growth factor deprivation in combination with a cytokine.
Mouser C, Antoniou E, Vassiliou E
Theor Biol Med Model. 2018; 15(1):8.
PMID: 29925399
PMC: 6011349.
DOI: 10.1186/s12976-018-0080-2.
Elevated expression of DNMT1 is associated with increased expansion and proliferation of hematopoietic stem cells co-cultured with human MSCs.
Ahmadnejad M, Amirizadeh N, Mehrasa R, Karkhah A, Nikougoftar M, Oodi A
Blood Res. 2017; 52(1):25-30.
PMID: 28401098
PMC: 5383583.
DOI: 10.5045/br.2017.52.1.25.
Zbtb1 prevents default myeloid differentiation of lymphoid-primed multipotent progenitors.
Zhang X, Lu Y, Cao X, Zhen T, Kovalovsky D
Oncotarget. 2016; 7(37):58768-58778.
PMID: 27542215
PMC: 5312274.
DOI: 10.18632/oncotarget.11356.
Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications.
Mangialardi G, Madeddu P
Curr Diab Rep. 2016; 16(5):43.
PMID: 27025211
PMC: 4819731.
DOI: 10.1007/s11892-016-0730-x.
Apoptosis, DAP-Kinase1 Expression and the Influences of Cytokine Milieu and Mesenchymal Stromal Cells on Ex Vivo Expansion of Umbilical Cord Blood-Derived Hematopoietic Stem Cells.
Amirizadeh N, Oodi A, Mehrasa R, Nikougoftar M
Indian J Hematol Blood Transfus. 2016; 32(1):67-77.
PMID: 26855509
PMC: 4733685.
DOI: 10.1007/s12288-015-0545-y.
The Sirt1 activator SRT3025 expands hematopoietic stem and progenitor cells and improves hematopoiesis in Fanconi anemia mice.
Zhang Q, Deater M, Schubert K, Marquez-Loza L, Pelz C, Sinclair D
Stem Cell Res. 2015; 15(1):130-40.
PMID: 26046330
PMC: 4516677.
DOI: 10.1016/j.scr.2015.05.007.
Tauroursodeoxycholic acid increases neural stem cell pool and neuronal conversion by regulating mitochondria-cell cycle retrograde signaling.
Xavier J, Morgado A, Rodrigues C, Sola S
Cell Cycle. 2014; 13(22):3576-89.
PMID: 25483094
PMC: 4613652.
DOI: 10.4161/15384101.2014.962951.
Mesenchymal stem cells as a feeder layer can prevent apoptosis of expanded hematopoietic stem cells derived from cord blood.
Mehrasa R, Vaziri H, Oodi A, Khorshidfar M, Nikogoftar M, Golpour M
Int J Mol Cell Med. 2014; 3(1):1-10.
PMID: 24551815
PMC: 3927388.
Identification of Hematopoietic Stem Cell Engraftment Genes in Gene Therapy Studies.
Powers J, Trobridge G
J Stem Cell Res Ther. 2014; 2013(Suppl 3).
PMID: 24383045
PMC: 3875223.
DOI: 10.4172/2157-7633.S3-004.
Post-translational regulation enables robust p53 regulation.
Shin Y, Chen K, Sayed A, Hencey B, Shen X
BMC Syst Biol. 2013; 7:83.
PMID: 23992617
PMC: 3844394.
DOI: 10.1186/1752-0509-7-83.
Update on small intestinal stem cells.
Tesori V, Puglisi M, Lattanzi W, Gasbarrini G, Gasbarrini A
World J Gastroenterol. 2013; 19(29):4671-8.
PMID: 23922464
PMC: 3732839.
DOI: 10.3748/wjg.v19.i29.4671.
Effect of EGF and FGF on the expansion properties of human umbilical cord mesenchymal cells.
Salehinejad P, Alitheen N, Mandegary A, Nematollahi-Mahani S, Janzamin E
In Vitro Cell Dev Biol Anim. 2013; 49(7):515-23.
PMID: 23708920
DOI: 10.1007/s11626-013-9631-3.
Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival.
Penna C, Perrelli M, Karam J, Angotti C, Muscari C, Montero-Menei C
J Cell Mol Med. 2013; 17(1):192-204.
PMID: 23305078
PMC: 3823149.
DOI: 10.1111/j.1582-4934.2012.01662.x.
Personalising docetaxel and G-CSF schedules in cancer patients by a clinically validated computational model.
Vainas O, Ariad S, Amir O, Mermershtain W, Vainstein V, Kleiman M
Br J Cancer. 2012; 107(5):814-22.
PMID: 22814580
PMC: 3425973.
DOI: 10.1038/bjc.2012.316.